Fit and well (finding)

Barrett’s oESophagus Trial 3 (BEST3): A trial of a new GP-based test for patients with heartburn symptoms

Year Started: 2017

The BEST3 Trial is a cluster randomised controlled trial comparing the Cytosponge™-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care. The following types of the samples are collected as part of the Trial methodology: • Cytosponge™ samples • Saliva samples (TFF3-positive Cytosponge™ cases) • Endoscopic biopsy samples including gastric cardia and clinically-indicated oesophageal biopsies Cytosponge™ and endoscopic biopsy samples will be further processed into FFPE blocks and tissue sections.



Access:
Closed to access
Type:
Clinical Trial
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Male

Adult (> 40 years)

1001 - 3000 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Saliva RT N/A Non-affected 0 - 10%
Tissue specimen Surgical procedure (procedure) RT N/A Affected 0 - 10%
Tissue specimen Surgical procedure (procedure) RT N/A Not applicable 100%


Female

Adult (> 40 years)

1001 - 3000 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Saliva RT N/A Non-affected 0 - 10%
Tissue specimen Surgical procedure (procedure) RT N/A Affected 0 - 10%
Tissue specimen Surgical procedure (procedure) RT N/A Not applicable 100%